Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
PEAK6's PFE Position: Q1 2026 in Review
PEAK6 sold out of Pfizer (PFE) in Q1 2026, closing a stake of 22,428 shares — an estimated $558K sold.
PEAK6 first reported a position in PFE in Q4 2024 and held it in 5 quarters. The position peaked at $558K in Q4 2025. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- PEAK6 reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- PEAK6 sold 22,428 Pfizer shares in Q1 2026, an estimated $558K.
- PEAK6 first reported a position in Pfizer in Q4 2024 and held it in 5 quarters.
- PEAK6's Pfizer position peaked at $558K in Q4 2025.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.